West Pharmaceutical Services Inc

Healthcare · Medical Instruments & Supplies

365.00$ +0.0% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

West Pharmaceutical Services Inc (WST) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Revenue" came in at 872 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement WST
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26	LTM
Revenue	377	382	388	398	399	416	416	448	432	422	443	469	456	475	491	527	548	580	671	724	707	729	720	772	686	708	716	754	748	732	695	702	747	749	698	766	804	805	845	872	3,327
Cost of Revenue	256	259	254	273	273	287	281	305	296	289	297	312	309	318	324	332	357	369	398	408	418	436	435	452	419	445	445	462	458	453	464	471	482	474	466	493	511	501	549	543	2,104
Gross Profit	121	123	134	125	126	129	135	143	136	133	147	158	147	158	167	195	191	212	273	316	289	293	285	320	268	263	271	292	290	279	231	231	265	274	233	273	294	304	296	329	1,223
Research & Development	9.0	9.6	10	10	9.1	9.7	9.6	11	10	9.8	9.8	9.6	9.3	10	11	11	13	13	12	14	13	14	15	14	14	16	17	17	16	18	18	18	16	19	16	19	17	22	16	20	74
Selling, General & Administrative	58	61	62	61	62	59	68	70	65	60	69	70	65	69	72	78	76	154	84	93	92	98	80	79	68	117	99	88	89	90	87	83	84	85	88	96	103	107	100	118	426
Total Operating Expenses	68	69	73	71	81	69	86	88	81	46	78	80	74	79	83	86	84	89	92	107	105	112	98	96	80	102	103	105	98	108	104	101	97	104	104	115	120	147	119	150	536
Operating Income	53	54	62	54	45	60	49	55	54	87	68	78	73	78	85	108	107	122	180	210	184	181	187	224	188	162	168	187	191	171	127	131	168	171	128	158	174	157	177	179	687
Interest Expense	1.8	0.9	1.8	2.0	1.1	2.1	1.8	2.2	1.9	2.2	2.2	1.9	2.0	1.9	2.0	1.9	2.0	2.7	1.8	1.8	1.7	3.1	2.1	1.8	2.1	1.6	2.2	2.6	2.9	1.1	1.5	1.5	0.7	0.8	0.4	0.1	0.1	5.3	1.9	2.6	9.9
Pre-Tax Income	49	53	60	42	65	62	56	62	63	67	72	82	67	80	89	107	103	119	180	220	188	182	195	233	141	132	164	190	191	172	132	133	168	167	114	162	174	165	180	180	700
Income Tax Expense	14	16	2.2	2.9	14	62	13	6.0	8.0	15	16	16	11	17	15	16	21	20	29	32	12	34	21	44	20	29	24	35	29	35	16	22	32	37	24	30	34	33	45	32	144
Net Income	38	39	61	39	51	-2.5	44	56	55	52	55	66	56	64	74	91	82	98	151	187	176	148	174	189	121	103	140	155	161	137	115	111	136	130	90	132	140	132	139	154	565
EBITDA	74	77	85	66	89	86	82	88	89	94	98	108	92	106	115	130	128	146	206	242	213	219	219	259	168	161	192	222	226	205	165	169	205	206	151	199	217	210	219	179	824

LTM = last twelve months (sum of the four most recent quarters).

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Income Statement

Cookie settings